[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 1959


AMA Arch Derm. 1959;79(3):381-382. doi:10.1001/archderm.1959.01560150123027

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In the minds of altogether too many practitioners of medicine, coccidioidomycosis is still considered to be a very rare, chronic, highly fatal, granulomatous infection worthy of study only by those who of necessity may very occasionally be brought into contact with such patients because of their practices being located in certain endemic geographic areas. The fact is that it is newly acquired each year by persons numbering in the thousands, among whom are many who are only in transit through the endemic region, or who otherwise soon leave it to travel elsewhere. There is ample time between exposure and the onset of clinical symptoms for any spot on the globe to be reached. If given proper care, almost all of these patients will recover completely; if not, some will die unnecessarily and under appropriate circumstances might cause new endemic foci. The diagnosis is usually not difficult, and all doctors should

First Page Preview View Large
First page PDF preview
First page PDF preview